IGF1R and Cerebral atrophy: In human studies, low serum levels of the IGF-1R ligand have been associated with increased risks of Alzheimer's and lower brain volume (cerebral atrophy), and higher serum levels of IGF-1R ligand are considered as a safeguard against various clinical and subclinical presentations of neurological degeneration [65–69].